Aggregatibacter (Actinobacillus) actinomycetemcomitans: A triple A* periodontopathogen?

Periodontology 2000

Volumn 54, Issue 1, 2010, Pages 78-105

  Henderson, Brian ^a   Ward, John M ^a   Ready, Derren ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; IRON;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BACTERIAL GENOME; BACTERIAL SECRETION SYSTEM; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; EPITHELIUM CELL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VIRULENCE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; ANIMALS; BACTERIAL ADHESION; BACTERIAL SECRETION SYSTEMS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; EPITHELIAL CELLS; GENOME, BACTERIAL; HUMANS; IRON; VIRULENCE;

EID: 77955745849     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2009.00331.x     Document Type: Article

References (266)

1. Albandar JM, Brown LJ, Löe H. Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis. J Periodontol 1997, 68:973-981.
2. Alnaeeli M, Penninger JM, Teng YT. Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells. J Immunol 2006, 177:3314-3326.
3. Amarasinghe JJ, Scannapieco FA, Haase EM. Transcriptional and translational analysis of biofilm determinants of Aggregatibacter actinomycetemcomitans in response to environmental perturbation. Infect Immun 2009, 77:2896-2907.
4. Asakawa R, Komatsuzawa H, Kawai T, Yamada S, Goncalves RB, Izumi S, Fujiwara T, Nakano Y, Suzuki N, Uchida Y, Ouhara K, Shiba H, Taubman MA, Kurihara H, Sugai M. Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans. Mol Microbiol 2003, 50:1125-1139.
5. Atieh MA. Accuracy of real-time polymerase chain reaction versus anaerobic culture in detection of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: a meta-analysis. J Periodontol 2008, 79:1620-1629.
6. Balashova NV, Crosby JA, Al Ghofaily L, Kachlany SC. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans. Infect Immun 2006, 74:2015-2021.
7. Balashova NV, Diaz R, Balashov SV, Crosby JA, Kachlany SC. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron. J Bacteriol 2006, 188:8658-8661.
8. Balashova NV, Shah C, Patel JK, Megalla S, Kachlany SC. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells. Gene 2009, 443:42-47.
9. Belibasakis GN, Brage M, Lagergård T, Johansson A. Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells. APMIS 2008, 116:499-506.
10. Belibasakis GN, Johansson A, Wang Y, Chen C, Kalfas S, Lerner UH. The cytolethal distending toxin induces receptor activator of NF-κB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect Immun 2005, 73:342-351.
11. Belibasakis GN, Johansson A, Wang Y, Chen C, Lagergård T, Kalfas S, Lerner UH. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005, 30:56-63.
12. Berthold P, Forti D, Kieba IR, Rosenbloom J, Taichman NS, Lally ET. Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immunol 1992, 7:24-27.
13. Boesze-Battaglia K, Brown A, Walker L, Besack D, Zekavat A, Wrenn S, Krummenacher C, Shenker BJ. Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol. J Biol Chem 2009, 284:10650-10658.
14. Branger J, Wieland CW, Florquin S, Maris NA, Pater JM, Speelman P, Shimizu T, Ishii S, van der Poll T. Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract. Shock 2004, 22:543-547.
15. Brissette CA, Fives-Taylor PM. Actinobacillus actinomycetemcomitans may utilize either actin-dependent or actin-independent mechanisms of invasion. Oral Microbiol Immunol 1999, 14:137-142.
16. Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 1994, 62:501-508.
17. Cann KL, Hicks GG. Regulation of the cellular DNA double-strand break response. Biochem Cell Biol 2007, 85:663-674.
18. Cao SL, Progulske-Fox A, Hillman JD, Handfield M. In vivo induced antigenic determinants of Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 2004, 237:97-103.
19. Celenligil H, Ebersole JL. Analysis of serum antibody responses to periodontopathogens in early-onset periodontitis patients from different geographical locations. J Clin Periodontol 1998, 25:994-1002.
20. Chen I, Gotschlich EC. ComE, a competence protein from Neisseria gonorrhoeae with DNA-binding activity. J Bacteriol 2001, 183:3160-3168.
21. Chenal A, Guijarro JI, Raynal B, Delepierre M, Ladant D. RTX calcium binding motifs are intrinsically disordered in the absence of calcium: implication for protein secretion. J Biol Chem 2009, 284:1781-1789.
22. Chin N, Frey J, Chang CF, Chang YF. Identification of a locus involved in the utilisation of iron by Actinobacillus pleuropneumoniae. FEMS Microbiol Lett 1996, 143:1-6.
23. Christersson LA. Actinobacillus actinomycetemcomitans and localized juvenile periodontitis. Clinical, microbiologic and histologic studies. Swed Dent J Suppl 1993, 90:1-46.
24. Clock SA, Planet PJ, Perez BA, Figurski DH. Outer membrane components of the Tad (tight adherence) secreton of Aggregatibacter actinomycetemcomitans. J Bacteriol 2008, 190:980-990.
25. Colombo AV, da Silva CM, Haffajee A, Colombo AP. Identification of intracellular oral species within human crevicular epithelial cells from subjects with chronic periodontitis by fluorescence in situ hybridization. J Periodontal Res 2007, 42:236-243.
26. Comayras C, Tasca C, Pérès SY, Ducommun B, Oswald E, De Rycke J. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 1997, 65:5088-5095.
27. Periodontal diseases: epidemiology and diagnosis. Ann Periodontol 1996, 1:16-22.
28. Contreras A, Rusitanonta T, Chen C, Wagner WG, Michalowicz BS, Slots J. Frequency of 530-bp deletion in Actinobacillus actinomycetemcomitans leukotoxin promoter region. Oral Microbiol Immunol 2000, 15:338-340.
29. Cotter SE, Surana NK, St Geme JW. Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol 2005, 13:199-205.
30. Crosby JA, Kachlany SC. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans. Gene 2007, 388:83-92.
31. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995, 377:435-438.
32. Demuth DR, James D, Kowashi Y, Kato S. Interaction of Actinobacillus actinomycetemcomitans outer membrane vesicles with HL60 cells does not require leukotoxin. Cell Microbiol 2003, 5:111-121.
33. Dileepan T, Kachlany SC, Balashova NV, Patel J, Maheswaran SK. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Infect Immun 2007, 75:4851-4856.
34. Dileepan T, Kannan MS, Walcheck B, Maheswaran SK. Integrin-EGF-3 domain of bovine CD18 is critical for Mannheimia haemolytica leukotoxin species-specific susceptibility. FEMS Microbiol Lett 2007, 274:67-72.
35. DiRienzo JM, Cao L, Volgina A, Bandelac G, Korostoff J. Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse. FEMS Microbiol Lett 2009, 291:222-231.
36. Donnenberg MS, Zhang HZ, Stone KD. Biogenesis of the bundle-forming pilus of enteropathogenic Escherichia coli: reconstitution of fimbriae in recombinant E. coli and role of DsbA in pilin stability - a review. Gene 1997, 192:33-38.
37. Dubnau D. Genetic competence in Bacillus subtilis. Microbiol Rev 1991, 55:395-424.
38. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000, 37:952-963.
39. Fabris AS, DiRienzo JM, Wïkstrom M, Mayer MP. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol Immunol 2002, 17:231-238.
40. Fernandes KP, Mayer MP, Ando ES, Ulbrich AG, Amarente-Mendes JG, Russo M. Inhibition of interferon-γ-induced nitric oxide production in endotoxin-activated macrophages by cytolethal distending toxin. Oral Microbiol Immunol 2008, 23:360-366.
41. Fine DH, Furgang D, Kaplan J, Charlesworth J, Figurski DH. Tenacious adhesion of Actinobacillus actinomycetemcomitans strain CU1000 to salivary-coated hydroxyapatite. Arch Oral Biol 1999, 44:1063-1076.
42. Fine DH, Furgang D, Schreiner HC, Goncharoff P, Charlesworth J, Ghazwan G, Fitzgerald-Bocarsly P, Figurski DH. Phenotypic variation in Actinobacillus actinomycetemcomitans during laboratory growth: implications for virulence. Microbiology 1999, 145:1335-1347.
43. Fine DH, Velliyagounder K, Furgang D, Kaplan JB. The Actinobacillus actinomycetemcomitans autotransporter adhesin Aae exhibits specificity for buccal epithelial cells from humans and old world primates. Infect Immun 2005, 73:1947-1953.
44. Fink DL, Buscher AZ, Green B, Fernsten P, St Geme JW. The Haemophilus influenzae Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding regions in the C-terminal end of the passenger domain. Cell Microbiol 2003, 5:175-186.
45. Fink DL, Green BA, St Geme JW. The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect Immun 2002, 70:4902-4907.
46. Frey J, Kuhnert P. RTX toxins in Pasteurellaceae. Int J Med Microbiol 2002, 292:149-158.
47. Fujita T, Ashikaga A, Shiba H, Uchida Y, Hirono C, Iwata T, Takeda K, Kishimoto A, Hirata R, Kawaguchi H, Shiba Y, Kurihara H. Regulation of IL-8 by Irsogladine maleate is involved in abolishment of Actinobacillus actinomycetemcomitans-induced reduction of gap-junctional intercellular communication. Cytokine 2006, 34:271-277.
48. Gafan GP, Lucas VS, Roberts GJ, Petrie A, Wilson M, Spratt DA. Prevalence of periodontal pathogens in dental plaque of children. J Clin Microbiol 2004, 42:4141-4146.
49. Gallant CV, Sedic M, Chicoine EA, Ruiz T, Mintz KP. Membrane morphology and leukotoxin secretion are associated with a novel membrane protein of Aggregatibacter actinomycetemcomitans. J Bacteriol 2008, 190:5972-5980.
50. Ganeshnarayan K, Shah SM, Libera MR, Santostefano A, Kaplan JB. Poly-N-acetylglucosamine matrix polysaccharide impedes fluid convection and transport of the cationic surfactant cetylpyridinium chloride through bacterial biofilms. Appl Environ Microbiol 2009, 75:1308-1314.
51. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. The dual role of p55 tumour necrosis factor-α receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol 2007, 147:128-138.
52. Garlet GP, Cardoso CR, Campanelli AP, Garlet TP, Avila-Campos MJ, Cunha FQ, Silva JS. The essential role of IFN-γ in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect 2008, 10:489-496.
53. Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, Fox JG. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 2007, 9:2070-2080.
54. Graber KR, Smoot LM, Actis LA. Expression of iron binding proteins and hemin binding activity in the dental pathogen Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 1998, 163:135-142.
55. Grenier D, Leduc A, Mayrand D. Interaction between Actinobacillus actinomycetemcomitans lipopolysaccharides and human hemoglobin. FEMS Microbiol Lett 1997, 151:77-81.
56. Guerra L, Teter K, Lilley BN, Stenerlöw B, Holmes RK, Ploegh HL, Sandvig K, Thelestam M, Frisan T. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 2005, 7:921-934.
57. Gupta S, Kass GE, Szegezdi E, Joseph B. The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 2009, 13:1004-1033.
58. Haase EM, Zmuda JL, Scannapieco FA. Identification and molecular analysis of rough-colony-specific outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun 1999, 67:2901-2908.
59. Haffajee AD. Plaque microbiology in (periodontal) health and disease. Periodontal Medicine and Systems Biology 2009, 59-76. Henderson BCurtis MASeymour RMDonos N. In, editors, Chichester, UK, Wiley-Blackwell
60. Haffajee AD, Japlit M, Bogren A, Kent RL, Goodson JM, Socransky SS. Differences in the subgingival plaque microbiota of Swedish and USA subjects who were periodontally healthy or exhibited minimal periodontal disease. J Clin Periodontol 2005, 32:33-39.
61. Han X, Kawai T, Eastcott JW, Taubman MA. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol 2006, 176:625-631.
62. Han X, Kawai T, Taubman MA. Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontol 2000 2007, 45:76-94.
63. Han X, Lin X, Seliger AR, Eastcott J, Kawai T, Taubman MA. Expression of receptor activator of nuclear factor-κB ligand by B cells in response to oral bacteria. Oral Microbiol Immunol 2009, 24:190-196.
64. Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol 2007, 73:1697-1702.
65. Harano K, Yamanaka A, Okuda K. An antiserum to a synthetic fimbrial peptide of Actinobacillus actinomycetemcomitans blocked adhesion of the microorganism. FEMS Microbiol Lett 1995, 130:279-285.
66. Haraszthy VI, Hariharan G, Tinoco EM, Cortelli JR, Lally ET, Davis E, Zambon JJ. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J Periodontol 2000, 71:912-922.
67. Haraszthy VI, Jordan SF, Zambon JJ. Identification of Fur-regulated genes in Actinobacillus actinomycetemcomitans. Microbiology 2006, 152:787-796.
68. Haraszthy VI, Lally ET, Haraszthy GG, Zambon JJ. Molecular cloning of the fur gene from Actinobacillus actinomycetemcomitans. Infect Immun 2002, 70:3170-3179.
69. Haubek D, Dirienzo JM, Tinoco EM, Westergaard J, López NJ, Chung CP, Poulsen K, Kilian M. Racial tropism of a highly toxic clone of Actinobacillus actinomycetemcomitans associated with juvenile periodontitis. J Clin Microbiol 1997, 35:3037-3042.
70. Haubek D, Ennibi OK, Poulsen K, Poulsen S, Benzarti N, Kilian M. Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. J Dent Res 2001, 80:1580-1583.
71. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008, 371:237-242.
72. Haubek D, Poulsen K, Asikainen S, Kilian M. Evidence for absence in Northern Europe of especially virulent clonal types of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1995, 33:395-401.
73. Haubek D, Poulsen K, Kilian M. Microevolution and patterns of dissemination of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Infect Immun 2007, 75:3080-3088.
74. Hayashida H, Poulsen K, Kilian M. Differences in iron acquisition from human haemoglobin among strains of Actinobacillus actinomycetemcomitans. Microbiology 2002, 148:3993-4001.
75. He T, Nishihara T, Demuth DR, Ishikawa I. A novel insertion sequence increases the expression of leukotoxicity in Actinobacillus actinomycetemcomitans clinical isolates. J Periodontol 1999, 70:1261-1268.
76. Heinrich S, Pulverer G. On the etiology and microbiology of actinomycosis. III. The pathogenic significance of Actinobacillus actinomycetem-comitans among the 'bacterial symbionts' of Actinomyces israeli. Zentralbl Bakteriol 1959, 176:91-101. (in German)
77. Henderson B, Nair SP. Hard labour: bacterial infection of the skeleton. Trends Microbiol 2003, 11:570-577.
78. Henderson B, Nair SP, Pallas J, Williams MA. Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin binding proteins. FEMS Microbiol Rev (in press)
79. Henderson B, Nair SP, Ward JM, Wilson M. Molecular pathogenicity of the oral opportunistic pathogen, Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 2003, 57:29-55.
80. Henderson B, Tabona P, Poole S, Nair SP. Cloning and expression of the Actinobacillus actinomycetemcomitans thioredoxin (trx) gene and assessment of cytokine inhibitory activity. Infect Immun 2001, 69:154-158.
81. Henderson B, Wilson M, Hyams J. Cellular microbiology: cycling into the millennium. Trends Cell Biol 1998, 8:384-387.
82. Heywood W, Henderson B, Nair SP. Cytolethal distending toxin: creating a gap in the cell cycle. J Med Microbiol 2004, 54:207-216.
83. Holm A, Rabe P, Kalfas S, Edwardsson S. Improved selective culture media for Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus. J Clin Microbiol 1987, 25:1985-1988.
84. Hoover JN, Ellegaard B, Attström R. Periodontal status of 14-16 year-old Danish schoolchildren. Scand J Dent Res 1981, 89:175-179.
85. Hritz M, Fisher E, Demuth DR. Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 1996, 64:2724-2729.
86. Hu X, Stebbins CE. Dynamics and assembly of the cytolethal distending toxin. Proteins 2006, 65:843-855.
87. Hutter G, Schlagenhauf U, Valenza G, Horn M, Burgemeister S, Claus H, Vogel U. Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens. Microbiology 2003, 149:67-75.
88. Iino Y, Hopps RM. The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths. Arch Oral Biol 1984, 29:59-63.
89. Inoue T, Ohta H, Tanimoto I, Shingaki R, Fukui K. Heterogeneous post-translational modification of Actinobacillus actinomycetemcomitans fimbrillin. Microbiol Immunol 2000, 44:715-718.
90. Inoue T, Tanimoto I, Ohta H, Kato K, Murayama Y, Fukui K. Molecular characterization of low-molecular-weight component protein, Flp, in Actinobacillus actinomycetemcomitans fimbriae. Microbiol Immunol 1998, 42:253-258.
91. Inouye T, Ohta H, Kokeguchi S, Fukui K, Kato K. Colonial variation and fimbriation of Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 1990, 57:13-17.
92. Isaza MP, Duncan MS, Kaplan JB, Kachlany SC. Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesis. Infect Immun 2008, 76:3561-3568.
93. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodontal Res 1991, 26:155-160.
94. Ishihara K, Honma K, Miura T, Kato T, Okuda K. Cloning and sequence analysis of the fimbriae associated protein (fap) gene from Actinobacillus actinomycetemcomitans. Microb Pathog 1997, 23:63-69.
95. Iwata T, Mitani A, Ishihara Y, Tanaka S, Yamamoto G, Kikuchi T, Naganawa T, Matsumura Y, Suga T, Koide M, Sobue T, Suzuki T, Noguchi T. Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1β mRNA expression through the JNK pathway in differentiated THP-1 cells. Clin Exp Immunol 2005, 141:261-269.
96. Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol 2008, 74:470-476.
97. Izano EA, Sadovskaya I, Wang H, Vinogradov E, Ragunath C, Ramasubbu N, Jabbouri S, Perry MB, Kaplan JB. Poly-N-acetylglucosamine mediates biofilm formation and detergent resistance in Aggregatibacter actinomycetemcomitans. Microb Pathog 2008, 44:52-60.
98. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 2007, 86:618-622.
99. Jain D, Prasad KN, Sinha S, Husain N. Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. J Med Microbiol 2008, 57:267-272.
100. Johansson A, Claesson R, Hänström L, Kalfas S. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans. Eur J Oral Sci 2003, 111:209-215.
101. Johansson A, Sandström G, Claesson R, Hänström L, Kalfas S. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity. Eur J Oral Sci 2000, 108:136-146.
102. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog 1988, 4:103-113.
103. Kachlany SC, Fine DH, Figurski DH. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect Immun 2000, 68:6094-6100.
104. Kachlany SC, Fine DH, Figurski DH. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans. Protein Expr Purif 2002, 25:465-471.
105. Kachlany SC, Planet PJ, Bhattacharjee MK, Kollia E, DeSalle R, Fine DH, Figurski DH. Nonspecific adherence by Actinobacillus actinomycetemcomitans requires genes widespread in bacteria and archaea. J Bacteriol 2000, 182:6169-6176.
106. Kachlany SC, Planet PJ, Desalle R, Fine DH, Figurski DH, Kaplan JB. flp-1, the first representative of a new pilin gene subfamily, is required for non-specific adherence of Actinobacillus actinomycetemcomitans. Mol Microbiol 2001, 40:542-554.
107. Kaplan JB, Perry MB, MacLean LL, Furgang D, Wilson ME, Fine DH. Structural and genetic analyses of O polysaccharide from Actinobacillus actinomycetemcomitans serotype f. Infect Immun 2001, 69:5375-5384.
108. Kaplan JB, Schreiner HC, Furgang D, Fine DH. Population structure and genetic diversity of Actinobacillus actinomycetemcomitans strains isolated from localized juvenile periodontitis patients. J Clin Microbiol 2002, 40:1181-1187.
109. Kaplan JB, Velliyagounder K, Ragunath C, Rohde H, Mack D, Knobloch JK, Ramasubbu N. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 2004, 186:8213-8220.
110. Kapperud G, Namork E, Skurnik M, Nesbakken T. Plasmid encoded surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis. Infect Immun 1987, 55:2247-2254.
111. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835.
112. Kato S, Kowashi Y, Demuth DR. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog 2002, 32:1-13.
113. Kato S, Muro M, Akifusa S, Hanada N, Semba I, Fujii T, Kowashi Y, Nishihara T. Evidence for apoptosis of murine macrophages by Actinobacillus actinomycetemcomitans infection. Infect Immun 1995, 63:3914-3919.
114. Keijser BJ, Zaura E, Huse M, van der Vossen JM, Schuren FH, Montjin RC, ten Cate JM, Crielaard W. Pyrosequencing analysis of the oral microbiota of healthy adults. J Dent Res 2008, 87:1016-1020.
115. Kelk P, Claesson R, Chen C, Sjöstedt A, Johansson A. IL-1β secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int J Med Microbiol 2008, 298:529-541.
116. Kelk P, Claesson R, Hänström L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive interleukin-1β by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005, 73:453-458.
117. Kelk P, Johansson A, Claesson R, Hänström L, Kalfas S. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2003, 71:4448-4455.
118. Kieba IR, Fong KP, Tang HY, Hoffman KE, Speicher DW, Klickstein LB, Lally ET. Aggregatibacter actinomycetemcomitans leukotoxin requires β-sheets 1 and 2 of the human CD11a β-propeller for cytotoxicity. Cell Microbiol 2007, 9:2689-2699.
119. Kirby AC, Meghji S, Nair SP, White P, Reddi K, Nishihara T, Nakashima K, Willis AC, Sim R, Wilson M, Henderson B. The potent bone-resorbing mediator of Actinobacillus actinomycetemcomitans is homologous to the molecular chaperone GroEL. J Clin Invest 1995, 96:1185-1194.
120. Kolodrubetz D, Spitznagel J, Wang B, Phillips LH, Jacobs C, Kraig E. cis elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans. Infect Immun 1996, 64:3451-3460.
121. Koschinski A, Repp H, Unver B, Dreyer F, Brockmeier D, Valeva A, Bhakdi S, Walev I. Why Escherichia coliα-hemolysin induces calcium oscillations in mammalian cells - the pore is on its own. FASEB J 2006, 20:973-975.
122. Korostoff J, Wang JF, Kieba I, Miller M, Shenker BJ, Lally ET. Actinobacillus actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells. Infect Immun 1998, 66:4474-4483.
123. Korostoff J, Yamaguchi N, Miller M, Kieba I, Lally ET. Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Microb Pathog 2000, 29:267-278.
124. Kram KE, Hovel-Miner GA, Tomich M, Figurski DH. Transcriptional regulation of the tad locus in Aggregatibacter actinomycetemcomitans: a termination cascade. J Bacteriol 2008, 190:3859-3868.
125. Krewulak KD, Vogel HJ. Structural biology of bacterial iron uptake. Biochim Biophys Acta 2008, 1778:1781-1804.
126. Kronauer E, Borsa G, Lang NP. Prevalence of incipient juvenile periodontitis at age 16 years in Switzerland. J Clin Periodontol 1986, 13:103-108.
127. Kumar PS, Griffen AL, Moeschberger ML, Leys EJ. Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin Microbiol 2005, 43:3944-3955.
128. Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, Griffen AL. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 2006, 44:3665-3673.
129. Kuramitsu HK, He X, Lux R, Anderson MH, Shi W. Interspecies interactions within oral microbial communities. Microbiol Mol Biol Rev 2007, 71:653-670.
130. Kurita-Ochiai T, Ochiai K. Immunosuppressive factor from Actinobacillus actinomycetemcomitans down regulates cytokine production. Infect Immun 1996, 64:50-54.
131. Lally ET, Hill RB, Kieba IR, Korostoff J. The interactions between RTX toxins and target cells. Trends Microbiol 1999, 7:356-361.
132. Lally ET, Kieba IR, Sato A, Green CL, Rosenbloom J, Korostoff J, Wang JF, Shenker BJ, Ortlepp S, Robinson MK, Billings PC. RTX toxins recognize a β2 integrin on the surface of human target cells. J Biol Chem 1997, 272:30463-30469.
133. Lamont RJ. Bacterial Invasion of Host Cells 2004, editor, Cambridge, UK, Cambridge University Press
134. Lara-Tejero M, Galán JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000, 290:354-357.
135. Lépine G, Caudry S, DiRienzo JM, Ellen RP. Epithelial cell invasion by Actinobacillus actinomycetemcomitans strains from restriction fragment-length polymorphism groups associated with juvenile periodontitis or carrier status. Oral Microbiol Immunol 1998, 13:341-347.
136. Leung NM, Chen R, Rudney JD. Oral bacteria in plaque and invading buccal cells of young orthodontic patients. Am J Orthod Dentofacial Orthop 2006, 130:698e11-698e18.
137. Löe H, Brown LJ. Early onset periodontitis in the United States of America. J Periodontol 1991, 62:608-616.
138. Lopez NJ, Mellado JC, Giglio MS, Leighton GX. Occurrence of certain bacterial species and morphotypes in juvenile periodontitis in Chile. J Periodontol 1995, 66:559-567.
139. Mandell RL, Socransky SS. A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis. J Periodontol 1981, 52:593-598.
140. Mangan DF, Taichman NS, Lally ET, Wahl SM. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991, 59:3267-3272.
141. Mans JJ, Baker HV, Oda D, Lamont RJ, Handfield M. Distinctive characteristics of transcriptional profiles from two epithelial cell lines upon interaction with Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2006, 21:261-267.
142. McSweeney LA, Dreyfus LA. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol 2004, 6:447-458.
143. Meghji S, Wilson M, Barber P, Henderson B. Bone resorbing activity of surface-associated material from Actinobacillus actinomycetemcomitans and Eikenella corrodens. J Med Microbiol 1994, 41:197-203.
144. Menestrina G, Moser C, Pellet S, Welch R. Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicology 1994, 87:249-267.
145. Meng H, Xu L, Li Q, Han J, Zhao Y. Determinants of host susceptibility in aggressive periodontitis. Periodontol 2000 2007, 43:133-159.
146. Meyer DH, Lippmann JE, Fives-Taylor PM. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: a dynamic, multistep process. Infect Immun 1996, 64:2988-2997.
147. Meyer DH, Rose JE, Lippmann JE, Fives-Taylor PM. Microtubules are associated with intracellular movement and spread of the periodontopathogen Actinobacillus actinomycetemcomitans. Infect Immun 1999, 67:6518-6525.
148. Meyer DH, Sreenivasan PK, Fives-Taylor PM. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect Immun 1991, 59:2719-2726.
149. Mintz KP. Identification of an extracellular matrix protein adhesin, EmaA, which mediates the adhesion of Actinobacillus actinomycetemcomitans to collagen. Microbiology 2004, 150:2677-2688.
150. Mitchell C, Gao L, Demuth DR. Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652. Infect Immun 2003, 71:5640-5649.
151. Mombelli A, Gmur R, Lang NP, Corbert E, Frey J. Actinobacillus actinomycetemcomitans in Chinese adults. Serotype distribution and analysis of the leukotoxin gene promoter locus. J Clin Periodontol 1999, 26:505-510.
152. Morova J, Osicka R, Masin J, Sebo P. RTX cytotoxins recognize β2 integrin receptors through N-linked oligosaccharides. Proc Natl Acad Sci U S A 2008, 105:5355-5360.
153. Morton DJ, Whitby PW, Jin H, Ren Z, Stull TL. Effect of multiple mutations in the haemoglobin and haemoglobin-haptoglobin-binding proteins HgpA, HgpB, HgpC, of Haemophilus influenzae type b. Infect Immun 1999, 67:2729-2739.
154. Mullen LM, Bossé JT, Nair SP, Ward JM, Rycroft AN, Robertson G, Langford PR, Henderson B. Pasteurellaceae ComE1 proteins combine the properties of fibronectin adhesins and DNA binding competence proteins. PLoS ONE 2008, 3:e3991.
155. Mullen LM, Nair SP, Ward JM, Rycroft AN, Williams RJ, Henderson B. Comparative functional genomic analysis of Pasteurellaceae adhesins using phage display. Vet Microbiol 2007, 122:123-134.
156. Mullen LM, Nair SP, Ward JM, Rycroft AN, Williams RJ, Robertson G, Mordan NJ, Henderson B. Novel adhesin from Pasteurella multocida that binds to the integrin-binding fibronectin FnIII9-10 repeats. Infect Immun 2008, 76:1093-1104.
157. Nagata H, Ikawa Y, Kuboniwa M, Maeda K, Shizukuishi S. Characterization of hemoglobin binding to Actinobacillus actinomycetemcomitans. Anaerobe 2002, 8:109-114.
158. Najar FZ. Sequence and analysis of Actinobacillus actinomycetemcomitans 2002, PhD Thesis, Norman, OK, University of Oklahoma
159. Najar FZ, Lin S, Song L, Lai H, White J, Kenton S, Roe BA. The Aggregatibacter (formerly Actinobacillus) actinomycetemcomitans genome - annotation, analysis and metabolic reconstruction. Periodontal Medicine and Systems Biology 2009, 219-244. Henderson B, Curtis MA, Seymour RM, Donos N, In, editors, Chichester, UK, Wiley-Blackwell
160. Nalbant A, Chen C, Wang Y, Zadeh HH. Induction of T-cell apoptosis by Actinobacillus actinomycetemcomitans mutants with deletion of ltxA and cdtABC genes: possible activity of GroEL-like molecule. Oral Microbiol Immunol 2003, 18:339-349.
161. Nesić D, Hsu Y, Stebbins CE. Assembly and function of a bacterial genotoxin. Nature 2004, 429:429-433.
162. Nibali L, Donos N, Henderson B. Periodontal infectogenomics. J Med Microbiol 2009, 58:1269-1274.
163. Nibali L, Ready DR, Parkar M, Brett PM, Wilson M, Tonetti MS, Griffiths GS. Gene polymorphisms and the prevalence of key periodontal pathogens. J Dent Res 2007, 86:416-420.
164. Nika JR, Latimer JL, Ward CK, Blick RJ, Wagner NJ, Cope LD, Mahairas GG, Munson RS, Hansen EJ. Haemophilus ducreyi requires the flp gene cluster for microcolony formation in vitro. Infect Immun 2002, 70:2965-2975.
165. Nishikubo S, Ohara M, Ikura M, Katayanagi K, Fujiwara T, Komatsuzawa H, Kurihara H, Sugai M. Single nucleotide polymorphism in the cytolethal distending toxin B gene confers heterogeneity in the cytotoxicity of Actinobacillus actinomycetemcomitans. Infect Immun 2006, 74:7014-7020.
166. Oelschlaeger TA, Guerry P, Kopecko DJ. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci U S A 1993, 90:6884-6888.
167. Offenbacher S, Barros SP, Beck JD. Rethinking periodontal inflammation. J Periodontol 2008, 79:1577-1584.
168. Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, Yoshida H, Shiratori Y, Omata M. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med 2000, 192:1601-1610.
169. Osawa R, Yoshida A, Masakiyo Y, Nagashima S, Ansai T, Watari H, Notomi T, Takehara T. Rapid detection of Actinobacillus actinomycetemcomitans using a loop-mediated isothermal amplification method. Oral Microbiol Immunol 2007, 22:252-259.
170. Pan Y, Teng D, Burke AC, Haase EM, Scannapieco FA. Oral bacteria modulate invasion and induction of apoptosis in Hep-2 cells by Pseudomonas aeruginosa. Microb Pathog 2009, 46:73-79.
171. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival plaque. J Bacteriol 2001, 183:3770-3783.
172. Perez BA, Planet PJ, Kachlany SC, Tomich M, Fine DH, Figurski DH. Genetic analysis of the requirement for flp-2, tadV, and rcpB in Actinobacillus actinomycetemcomitans biofilm formation. J Bacteriol 2006, 188:6361-6375.
173. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005, 366:1809-1820.
174. Planet PJ, Kachlany SC, Fine DH, DeSalle R, Figurski DH. The widespread colonization island of Actinobacillus actinomycetemcomitans. Nat Genet 2003, 34:193-198.
175. Pop C, Salvesen GS. Human caspases: activation, specificity and regulation. J Biol Chem 2009, 284:21777-21781.
176. Poulsen K, Theilade E, Lally ET, Demuth DR, Kilian M. Population structure of Actinobacillus actinomycetemcomitans: a framework for studies of disease-associated properties. Microbiology 1994, 140:2049-2060.
177. Provvedi R, Dubnau D. ComEA is a DNA receptor for transformation of competent Bacillus subtilis. Mol Microbiol 1999, 31:271-280.
178. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW, Plaut AG. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci U S A 1998, 95:12641-12646.
179. Rabie G, Lally ET, Shenker BJ. Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 1988, 56:122-127.
180. Ramasubbu N, Thomas LM, Ragunath C, Kaplan JB. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol 2005, 349:475-486.
181. Ramsey MM, Whiteley M. Polymicrobial interactions stimulate resistance to host innate immunity through metabolite perception. Proc Natl Acad Sci USA 2009, 106:1578-1583.
182. Ready D, D'Aiuto F, Spratt DA, Suvan J, Tonetti MS, Wilson M. Disease severity associated with presence in subgingival plaque of Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Tannerella forsythia, singly or in combination, as detected by nested multiplex PCR. J Clin Microbiol 2008, 46:3380-3383.
183. Redfield RJ, Findlay WA, Bosse J, Kroll JS, Cameron ADS, Nash JHE. Evolution of competence and DNA uptake specificity in the Pasteurellaceae. BMC Evol Biol 2006, 6:82.
184. Rhodes ER, Menke S, Shoemaker C, Tomaras AP, McGillivary G, Actis LA. Iron acquisition in the dental pathogen Actinobacillus actinomycetemcomitans: what does it use as a source and how does it get this essential metal? Biometals 2007, 20:365-377.
185. Rhodes ER, Tomaras AP, McGillivary G, Connerly PL, Actis LA. Genetic and functional analyses of the Actinobacillus actinomycetemcomitans AfeABCD siderophore-independent iron acquisition system. Infect Immun 2005, 73:3758-3763.
186. Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, Giannobile WV, Kirkwood KL. Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol 2007, 78:550-558.
187. Rosan B, Slots J, Lamont RJ, Listgarten MA, Nelson GM. Actinobacillus actinomycetemcomitans fimbriae. Oral Microbiol Immunol 1988, 3:58-63.
188. Rose F, Kiss L, Grimminger F, Mayer K, Grandel U, Seeger W, Bieniek E, Sibelius U. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. Am J Physiol Lung Cell Mol Physiol 2000, 279:L100-L109.
189. Rose JE, Meyer DH, Fives-Taylor PM. Aae, an autotransporter involved in adhesion of Actinobacillus actinomycetemcomitans to epithelial cells. Infect Immun 2003, 71:2384-2393.
190. Rossa C, Liu M, Kirkwood KL. A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-κB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide. J Periodontal Res 2008, 43:201-211.
191. Rudney JD, Chen R, Sedgewick GJ. Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun 2001, 69:2700-2707.
192. Rudney JD, Chen R, Sedgewick GJ. Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are components of a polymicrobial intracellular flora within human buccal cells. J Dent Res 2005, 84:59-63.
193. Ruiz T, Lenox C, Radermacher M, Mintz KP. Novel surface structures are associated with the adhesion of Actinobacillus actinomycetemcomitans to collagen. Infect Immun 2006, 74:6163-6170.
194. Rylev M, Kilian M. Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 2008, 35(Suppl. 8):346-361.
195. Saarela M, Asikainen S, Alaluusua S, Pyhälä L, Lai CH, Jousimies-Somer H. Frequency and stability of mono- or poly-infection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e. Oral Microbiol Immunol 1992, 7:277-279.
196. Sanz M, van Winkelhoff AJ, Herrera D, Dellemijn-Kippuw N, Simón R, Winkel E. Differences in the composition of the subgingival microbiota of two periodontitis populations of different geographical origin. A comparison between Spain and The Netherlands. Eur J Oral Sci 2000, 108:383-392.
197. Saxen L. Prevalence of juvenile periodontitis in Finland. J Clin Periodontol 1980, 7:177-186.
198. Schaeffer LM, Schmidt ML, Demuth DR. Induction of Aggregatibacter actinomycetemcomitans leukotoxin expression by IS1301 and orfA. Microbiology 2008, 154:528-538.
199. Schrago CG, Russo CAM. Timing the origin of new world monkeys. Mol Biol Evol 2003, 20:1620-1625.
200. Schett G. Osteoimmunology in rheumatic diseases. Arthritis Res Ther 2009, 11:210.
201. Schreiner HC, Sinatra K, Kaplan JB, Furgang D, Kachlany SC, Planet PJ, Perez BA, Figurski DH, Fine DH. Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model. Proc Natl Acad Sci U S A 2003, 100:7295-7300.
202. Schenkein HA, Barbour SE, Berry CR, Kipps B, Tew JG. Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor. Infect Immun 2000, 68:5416-5419.
203. Schryvers AB, Stojiljkovic I. Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol 1999, 32:1117-1123.
204. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994, 62:244-251.
205. Shenker BJ, Besack D, McKay T, Pankoski L, Zekavat A, Demuth DR. Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J Immunol 2004, 172:410-417.
206. Shenker BJ, Besack D, McKay T, Pankoski L, Zekavat A, Demuth DR. Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity. J Immunol 2005, 174:2228-2234.
207. Shenker BJ, Dlakic M, Walker LP, Besack D, Jaffe E, LaBelle E, Boesze-Battaglia K. A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J Immunol 2007, 178:5099-5108.
208. Shenker BJ, Hoffmaster RH, McKay TL, Demuth DR. Expression of the cytolethal distending toxin (Cdt) operon in Actinobacillus actinomycetemcomitans: evidence that the CdtB protein is responsible for G2 arrest of the cell cycle in human T cells. J Immunol 2000, 165:2612-2618.
209. Shenker BJ, Hoffmaster RH, Zekavat A, Yamaguchi N, Lally ET, Demuth DR. Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J Immunol 2001, 167:435-441.
210. Shenker BJ, McKay T, Datar S, Miller M, Chowhan R, Demuth D. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 1999, 162:4773-4780.
211. Shenker BJ, Vitale LA, Welham DA. Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect Immun 1990, 58:3856-3862.
212. Shibuya N, Amano K, Azuma J, Nishihara T, Kitamura Y, Noguchi T, Koga T. 6-Deoxy-d-talan and 6-deoxy-l-talan. Novel serotype-specific polysaccharide antigens from Actinobacillus actinomycetemcomitans. J Biol Chem 1991, 266:16318-16323.
213. Skals M, Jorgensen NR, Leipziger J, Praetorius HA. α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc Natl Acad Sci U S A 2009, 106:4030-4035.
214. Sliepen I, Hofkens J, Van Essche M, Quirynen M, Teughels W. Aggregatibacter actinomycetemcomitans adhesion inhibited in a flow cell. Oral Microbiol Immunol 2008, 23:520-524.
215. Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1982, 15:606-609.
216. Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 1999, 20:82-121.
217. Socransky SS, Haffajee AD, Dzink JL, Hillman JD. Associations between microbial species in subgingival plaque samples. Oral Microbiol Immunol 1988, 3:1-7.
218. Socransky SS, Haffajee AD, Smith C, Martin L, Haffajee JA, Uzel NG, Goodson JM. Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol 2004, 19:352-362.
219. Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE. 'Checkerboard' DNA-DNA hybridization. BioTechniques 1994, 17:788-792.
220. Spinola SM, Fortney KR, Katz BP, Latimer JL, Mock JR, Vakevainen M, Hansen EJ. Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans. Infect Immun 2003, 71:7178-7182.
221. Spitznagel J, Kraig E, Kolodrubetz D. The regulation of leukotoxin production in Actinobacillus actinomycetemcomitans strain JP2. J Biol Chem 1994, 269:31289-31295.
222. Sreenivasan PK, Meyer DH, Fives-Taylor PM. Requirements for invasion of epithelial cells by Actinobacillus actinomycetemcomitans. Infect Immun 1993, 61:1239-1245.
223. Stabholz A, Mann J, Agmon S, Soskolne WA. The description of a unique population with a very high prevalence of localized juvenile periodontitis. J Clin Periodontol 1998, 25:872-878.
224. Suerbaum S, Josenhans C, Sterzenbach T, Drescher B, Brandt P, Bell M, Droge M, Fartmann B, Fischer HP, Ge Z, Horster A, Holland R, Klein K, Konig J, Macko L, Mendz GL, Nyakatura G, Schauer DB, Shen Z, Weber J, Frosch M, Fox JG. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A 2003, 100:7901-7906.
225. St Geme JW, Cutter D, Barrenkamp SJ. Characterization of the genetic locus encoding Haemophilus influenza type b fibril. J Bacteriol 1996, 178:6281-6287.
226. Sugai M, Kawamoto T, Pérès SY, Ueno Y, Komatsuzawa H, Fujiwara T, Kurihara H, Suginaka H, Oswald E. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998, 66:5008-5019.
227. Syed SA, Loesche WJ. Survival of human dental plaque flora in various transport media. Appl Microbiol 1972, 24:638-644.
228. Taichman NS, Iwase M, Lally ET, Shattil SJ, Cunningham ME, Korchak HM. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J Immunol 1991, 147:3587-3594.
229. Takahashi N, Koide M, Noguchi T, Suda T. Current paradigms of osteoblast-osteoclast interactions and bacterial pathogen-induced bone resorption. Periodontal Medicine and Systems Biology 2009, 379-393. Henderson B, Curtis MA, Seymour RM, Donos N. In, editors, Chichester, UK, Wiley-Blackwell
230. Takashima E, Konishi K. Characterization of a quinol peroxidase mutant in Aggregatibacter actinomycetemcomitans. FEMS Microbiol Lett 2008, 286:66-70.
231. Tan KS, Song KP, Ong G. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J Periodontal Res 2002, 37:268-272.
232. Tang G, Kitten T, Munro CL, Wellman GC, Mintz KP. EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis. Infect Immun 2008, 76:2316-2324.
233. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005, 76(Suppl. 11):2033-2041.
234. Teng YT, Hu W. Expression cloning of a periodontitis-associated apoptotic effector, cagE homologue, in Actinobacillus actinomycetemcomitans. Biochem Biophys Res Commun 2003, 303:1086-1094.
235. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000, 106:R59-R67.
236. Teng Y-T. Immune cell involvement in periodontal bone loss. Periodontal Medicine and Systems Biology 2009, 407-426. Henderson BCurtis MASeymour RMDonos N. In, editors, Chichester, UK, Wiley-Blackwell
237. Teng Y-T, Zhang X. Apoptotic activity and sub-cellular localization of a T4SS-associated CagE-homologue in Actinobacillus actinomycetemcomitans. Microb Pathog 2005, 38:125-132.
238. Teughels W, Kinder Haake S, Sliepen I, Pauwels M, Van Eldere J, Cassiman JJ, Quirynen M. Bacteria interfere with Aa colonization. J Dent Res 2007, 86:611-617.
239. Teughels W, Sliepen I, Quirynen M, Haake SK, Van Eldere J, Fives-Taylor P, Van Ranst M. Human cytomegalovirus enhances Aa adherence to cells. J Dent Res 2007, 86:175-180.
240. Tomich M, Fine DH, Figurski DH. The TadV protein of Actinobacillus actinomycetemcomitans is a novel aspartic acid prepilin peptidase required for maturation of the Flp1 pilin and TadE and TadF pseudopilins. J Bacteriol 2006, 188:6899-6914.
241. Tonetti MS, Mombelli A. Early-onset periodontitis. Ann Periodontol 1999, 4:39-53.
242. Tran SD, Rudney JD. Multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. J Clin Microbiol 1996, 34:2674-2678.
243. Tran SD, Rudney JD. Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. J Clin Microbiol 1999, 37:3504-3508.
244. Tsuzukibashi O, Takada K, Saito M, Kimura C, Yoshikawa T, Makimura M, Hirasawa M. A novel selective medium for isolation of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Periodontal Res 2008, 43:544-548.
245. Uchida Y, Shiba H, Komatsuzawa H, Hirono C, Ashikaga A, Fujita T, Kawaguchi H, Sugai M, Shiba Y, Kurihara H. Irsogladine maleate influences the response of gap junctional intercellular communication and IL-8 of human gingival epithelial cells following periodontopathogenic bacterial challenge. Biochem Biophys Res Commun 2005, 333:502-507.
246. Ueda N, Koide M, Ohguchi M, Ishihara Y, Noguchi T, Okahashi N, Nishihara T. Involvement of prostaglandin E2 and interleukin-1α in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J Periodontal Res 1998, 33:509-516.
247. Ueda N, Nishihara T, Ishihara Y, Amano K, Kuroyanagi T, Noguchi T. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4. Oral Microbiol Immunol 1995, 10:69-75.
248. Valeva A, Walev I, Kemmer H, Weis S, Siegel I, Boukhallouk F, Wassenaar TM, Chavakis T, Bhakdi S. Binding of Escherichia coli hemolysin and activation of the target cells is not receptor-dependent. J Biol Chem 2005, 280:36657-36663.
249. Van Essche M, Quirynen M, Sliepen I, Van Eldere J, Teughels W. Bdellovibrio bacteriovorus attacks Aggregatibacter actinomycetemcomitans. J Dent Res 2009, 88:182-186.
250. van Winkelhoff AJ, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 1999, 20:122-135.
251. Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB. Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing. Microb Pathog 2008, 45:173-180.
252. Wada N, Maeda H, Yoshimine Y, Akamine A. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Bone 2004, 35:629-635.
253. Wagaiyu EG, Wagaiyu CK. Prevalence of juvenile periodontitis in national youth service trainees. East Afr Med J 1992, 69:31-33.
254. Wang Y, Chen C. Mutational analysis of the flp operon in Actinobacillus actinomycetemcomitans. Gene 2005, 351:61-71.
255. Willemsen PT, Vulto I, Boxem M, de Graaff J. Characterization of a periplasmic protein involved in iron utilization of Actinobacillus actinomycetemcomitans. J Bacteriol 1997, 179:4949-4952.
256. Wilson M, McNab R, Henderson B. Bacterial Disease Mechanisms: An Introduction to Cellular Microbiology 2002, Cambridge, UK, Cambridge University Press
257. Xynogala I, Volgina A, DiRienzo JM, Korostoff J. Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis. Oral Microbiol Immunol 2009, 24:116-123.
258. Yamada T, Komoto J, Saiki K, Konishi K, Takusagawa F. Variation of loop sequence alters stability of cytolethal distending toxin (CDT): crystal structure of CDT from Actinobacillus actinomycetemcomitans. Protein Sci 2006, 15:362-372.
259. Yamaguchi N, Kieba IR, Korostoff J, Howard PS, Shenker BJ, Lally ET. Maintenance of oxidative phosphorylation protects cells from Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Cell Microbiol 2001, 3:811-823.
260. Yamamoto S, Mogi M, Kinpara K, Ishihara Y, Ueda N, Amano K, Nishihara T, Noguchi T, Togari A. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. J Dent Res 1999, 78:1230-1237.
261. Yoshida Y, Suzuki N, Nakano Y, Shibuya K, Ogawa Y, Koga T. Distribution of Actinobacillus actinomycetemcomitans serotypes and Porphyromonas gingivalis in Japanese adults. Oral Microbiol Immunol 2003, 18:135-139.
262. Young VB, Knox KA, Pratt JS, Cortez JS, Mansfield LS, Rogers AB, Fox JG, Schauer DB. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 2004, 72:2521-2527.
263. Yu C, Ruiz T, Lenox C, Mintz KP. Functional mapping of an oligomeric autotransporter adhesin of Aggregatibacter actinomycetemcomitans. J Bacteriol 2008, 190:3098-3109.
264. Yue G, Kaplan JB, Furgang D, Mansfield KG, Fine DH. A second Aggregatibacter actinomycetemcomitans autotransporter adhesin exhibits specificity for buccal epithelial cells in humans and Old World primates. Infect Immun 2007, 75:4440-4448.
265. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985, 12:1-20.
266. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57:1605-1615.